Scientists developed a successful method to make truly personalized predictions of future disease outcomes for patients with certain types of chronic blood cancers
Together, the companies will leverage expertise in genomics and molecular information to enhance the development of personalized medicines and care for patients with cancer
A novel personalized vaccine made using patients’ tumor tissue and immune cells stimulates potent therapeutic immune responses, extending overall survival of patients with recurrent ovarian cancer